Interestingly, a variant of the human melatonin receptor 1 b gene (MTRB1) has been associated with high plasma glucose levels, reduction of insulin response to glucose, and increased risk of T2D (16–18). This evidence concerns the gene INS and type 2 diabetes mellitus.